Eric Sherman

20PUBLICATIONS
86CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Natural language processingMolecular targetsPhycology (incl. marine grasses)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|May 08, 2026
Ficerafusp Alfa (BCA101) With Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Two-Year Results of an Expansion Cohort of a Phase I/Ib Trial.

|Jun 18, 2025
Optimizing Outcomes After Transoral Robotic Surgery for Oropharyngeal Carcinoma: Reflections on the ASCO Guideline.

Amir H Safavi, Nadeem Riaz, Eric J Sherman

|Oct 15, 2024
Performance of Retrieval-Augmented Large Language Models to Recommend Head and Neck Cancer Clinical Trials.

Tony K W Hung, Gilad J Kuperman, Eric J Sherman

|Oct 01, 2024
Phase 2 Trial of Regorafenib in Recurrent/Metastatic Adenoid Cystic Carcinoma.

Antoine Desilets, Joris L Vos, Nora Katabi

|Jun 26, 2024
Combination Targeted Therapy with Pembrolizumab and Lenvatinib in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers.

Jena D French, Bryan R Haugen, Francis P Worden

|May 24, 2024
Reply to A.S. Garden.

Nancy Y Lee, Eric J Sherman, Nadeem Riaz

Pageof 4

Frequent Collaborators

4 joint publications

Nancy Y Lee

4 joint publications

Luc G T Morris

4 joint publications

Nadeem Riaz

4 joint publications

Alan L Ho